<code id='F1B64F3ABF'></code><style id='F1B64F3ABF'></style>

<acronym id='F1B64F3ABF'></acronym>

<center id='F1B64F3ABF'><center id='F1B64F3ABF'><tfoot id='F1B64F3ABF'></tfoot></center><abbr id='F1B64F3ABF'><dir id='F1B64F3ABF'><tfoot id='F1B64F3ABF'></tfoot><noframes id='F1B64F3ABF'>

<optgroup id='F1B64F3ABF'><strike id='F1B64F3ABF'><sup id='F1B64F3ABF'></sup></strike><code id='F1B64F3ABF'></code></optgroup>

<b id='F1B64F3ABF'><label id='F1B64F3ABF'><select id='F1B64F3ABF'><dt id='F1B64F3ABF'><span id='F1B64F3ABF'></span></dt></select></label></b><u id='F1B64F3ABF'></u>

~~<i id='F1B64F3ABF'><strike id='F1B64F3ABF'><tt id='F1B64F3ABF'><pre id='F1B64F3ABF'></pre></tt></strike></i>~~

Home» explore» knowledge

knowledge

knowledge

author：comprehensive 2025-10-04 04:28:58 Page View：18335

light shines behind Pfizer CEO Albert Bourla as he attends a ceremony in Greece — Pfizer CEO Albert Bourla Giannis Papanikos/AP

Pfizer has a big problem. The drug giant hopes that new drugs to treat cancer are the solution.

Shares in the drugmaker fell 44% last year, and it now has a market capitalization of only $150 billion — a quarter that of Eli Lilly and half that of longtime rival Merck. In March of last year the company announced that it would spend $43 billion to buy Seagen, a maker of a hot category of oncology medicines called antibody-drug conjugates. Pfizer’s shares have slumped another 9% so far this year. On Thursday, executives are holding an investor briefing to try to convince shareholders that its bet will pay off.

advertisement

In an interview with STAT, Pfizer CEO Albert Bourla was insistent that the deal’s potential is being missed.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Asbestos, a deadly carcinogen, banned by EPA
Next article： Bright Health sells Medicare Advantage business to Molina

knowledge

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

WASHINGTON--TheSupremeCourtwillreviewarulingstrikingdownadomesticviolencefederalgunban.

Merus drug and Keytruda shrank tumors in patients with head and neck cancer

Merus drug and Keytruda shrank tumors in patients with head and neck cancer

ThisimmunofluorescenceimageshowsTcells(ingreenandyellow)inthemicroenvironmentofaheadandnecksquamousc

Peter Hotez and the public health issue of online harassment

Peter Hotez and the public health issue of online harassment

AdobeFather’sDayweekendwasanythingbutcalmonTwitter,whicheruptedasvaccineexpertPeterHotezwaschallenge

Methadone treatment changes are coming. Do they go far enough?

AdoseofmethadoneKevinD.Liles/APThefederalgovernmentisreformingmethadonecareforthefirsttimeinovertwod

read more